Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'BRYAN, T.
Right arrow Articles by HOSTETTER, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'BRYAN, T.
Right arrow Articles by HOSTETTER, T. H.
J Am Soc Nephrol 11:1067-1074, 2000
© 2000 American Society of Nephrology

REGULAR ARTICLES

Course of Renal Injury in the Mpv17-Deficient Transgenic Mouse

THOMAS O'BRYAN*, HANS WEIHER{dagger}, HELMUT G. RENNKE{ddagger}, STEFAN KREN* and THOMAS H. HOSTETTER*

* Renal Division, University of Minnesota, Minneapolis Minnesota
{dagger} Institut für Diabetes Forschung, Munich, Germany
{ddagger} Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.

Correspondence to Dr. Thomas H. Hostetter, Renal Division, Box 736 UMHC, 420 Delaware Street SE, Minneapolis, MN 55455. Phone: 612-624-6917; Fax: 612-626-3840; E-mail: hoste002{at}maroon.tc.umn.edu

Abstract. The mutant Mpv17 mouse is a transgenic strain that fails to express a protein that is normally expressed in the kidney and that is associated with peroxisomes. The present studies provide a quantitative examination of renal function and structure in this strain compared to its control CFW strain. By 52 wk of age, the mutant strain developed proteinuria (urinary protein to creatinine ratio: 25 ± 14 versus 3 ± 1, mutant versus control), albuminuria (urinary albumin to creatinine ratio: 23 ± 15 versus 0.1 ± 0.1, mutant versus control), and hypoalbuminemia (2.1 ± 0.4 versus 2.5 ± 0.2 G/dl, mutant versus control), but without arterial hypertension or major reduction in filtration (serum creatinine 0.14 ± 0.04 versus 0.18 ± 0.12 mg/dl, mutant versus control). The Mpv17 glomeruli were enlarged (0.98 ± 0.12 versus 0.52 ± 0.02 µm3 x 106, mutant versus control). Glomerular sclerosis became widespread (95 ± 3 versus 23 ± 32%, mutant versus control) and was preceded by mesangiolysis and microaneurysms. Tubulointerstitial disease was conspicuous by its absence. The intrarenal vasculature was normal in the mutant mice. Electron microscopy demonstrated focal foot process fusion and mesangiolysis. Thus, this mutant strain of mouse develops proteinuria and a distinct glomerulopathy including mesangiolysis but little interstitial injury all due to the loss of expression of a single gene.




This article has been cited by other articles:


Home page
 J. Am. Soc. Nephrol.Home page
L. Musante, G. Candiano, A. Petretto, M. Bruschi, N. Dimasi, G. Caridi, B. Pavone, P. Del Boccio, M. Galliano, A. Urbani, et al.
Active Focal Segmental Glomerulosclerosis Is Associated with Massive Oxidation of Plasma Albumin
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 799 - 810.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. A. Nath, J. P. Grande, J. J. Haggard, A. J. Croatt, Z. S. Katusic, A. Solovey, and R. P. Hebbel
Oxidative Stress and Induction of Heme Oxygenase-1 in the Kidney in Sickle Cell Disease
Am. J. Pathol., March 1, 2001; 158(3): 893 - 903.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673